Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 6/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | IL1RN | P18510 | 2/20 | 0.50 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.50 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.49 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13599555 | 1.00 | MC4R (0.54) | MC4RKMT2AMEN1HCRTR1MAPT | |
| SCHEMBL17820857 | 0.93 | MC4R (0.57) | MC4R | |
| SCHEMBL17827361 | 0.93 | MC4R (0.57) | MC4R | |
| SCHEMBL17827250 | 0.92 | MC4R (0.55) | MC4R | |
| SCHEMBL13599541 | 0.90 | MC4R (0.56) | MC4RKMT2AMEN1HCRTR1MAPT | |
| SCHEMBL19444239 | 0.90 | MEN1 (0.57) | KMT2AMEN1HCRTR1MAPTTP53 | |
| SCHEMBL13901677 | 0.89 | MC4R (0.56) | MC4RNPBWR1 | |
| SCHEMBL13901682 | 0.88 | MC4R (0.57) | MC4R | |
| SCHEMBL13599554 | 0.88 | CTSL (0.51) | MC4RKMT2AMEN1HCRTR1MAPT | |
| SCHEMBL13599544 | 0.88 | MC4R (0.51) | MC4RKMT2AMEN1HCRTR1IL1RN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015033743-A1 | METHOD FOR PREPARING LABELED SUGAR CHAIN SAMPLE | 住友ベークライト株式会社 (JP) | 2015-03-12 | — | — | WO | claimed |
| US-20110089033-A1 | METHOD OF PREPARING SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD OF ANALYZING SUGAR CHAIN | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-04-21 | — | — | US | claimed |
| EP-2295962-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | Sumitomo Bakelite Co., Ltd. (JP) | 2011-03-16 | — | — | EP | claimed |
| WO-2009150834-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | 住友ベークライト株式会社 (JP) | 2009-12-17 | — | — | WO | claimed |
| EP-3034495-A1 | COMPOUND FOR LABELLING SUGAR CHAIN SAMPLE | Sumitomo Bakelite Co.,Ltd. (JP) | 2016-06-22 | — | — | EP | disclosed |
| US-20160168196-A1 | COMPOUND FOR LABELING SUGAR CHAIN SAMPLE | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| WO-2015033743-A1 | METHOD FOR PREPARING LABELED SUGAR CHAIN SAMPLE | 住友ベークライト株式会社 (JP) | 2015-03-12 | — | — | WO | disclosed |
| US-20120070902-A1 | METHOD FOR ANALYSIS OF SUGAR CHAINS BY MASS SPECTROMETRY | SUMITOMO BAKELITE CO., LTD. (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20110089033-A1 | METHOD OF PREPARING SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD OF ANALYZING SUGAR CHAIN | SUMITOMO BAKELITE CO., LTD. (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-2295962-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | Sumitomo Bakelite Co., Ltd. (JP) | 2011-03-16 | — | — | EP | disclosed |
| WO-2009150834-A1 | METHOD FOR PREPARATION OF SUGAR CHAIN SAMPLE, SUGAR CHAIN SAMPLE, AND METHOD FOR ANALYSIS OF SUGAR CHAIN | 住友ベークライト株式会社 (JP) | 2009-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168196-A1 | COMPOUND FOR LABELING SUGAR CHAIN SAMPLE | SLC2A4, SLC2A2, SLC2A1 | MC4R 601/4885KMT2A 1645/4885MEN1 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.